Mirae Asset Global Etfs Holdings Ltd. Aerovate Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 7,438 shares of AVTE stock, worth $18,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,438
Previous 4,881
52.39%
Holding current value
$18,074
Previous $8,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AVTE
# of Institutions
80Shares Held
28MCall Options Held
116KPut Options Held
26.6K-
Ra Capital Management, L.P. Boston, MA9.19MShares$22.3 Million0.27% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA3.76MShares$9.13 Million0.74% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$5.45 Million0.61% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.37 Million0.79% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$3.43 Million0.05% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $59.4M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...